Nectar Lifesciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nectar Lifesciences Ltd. on BSE

Load latest

Nectar Lifesciences Ltd.

08 Sep 2010

Corp. Note

NecLife announces the receipt of KFDA approval for entry into South Korea

BSE India

Nectar Lifesciences Ltd has submitted to BSE a copy of an Investor Information release that the Company has received approval from Korean FDA (KFDA) for key product i.e. Cefuroxime Axetil (Amorphous).Announcement:"Nectar Lifesciences Ltd (NecLife), a leading integrated pharmaceutical organization in India, today announced that it has received approval from Korean FDA (KFDA) for key product i.e. Cefuroxime Axetil (Amorphous)....

pdf

Nectar Lifesciences Ltd.

13 Aug 2010

Corp. Note

Fixes Book Closure for AGM

BSE India

Nectar Lifesciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 25, 2010 to September 29, 2010 (both days inclusive) for the purpose of 15th Annual General Meeting (AGM) of the Company to be held on September 29, 2010.

Nectar Lifesciences Ltd.

12 Aug 2010

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

pdf

Nectar Lifesciences Ltd.

11 Aug 2010

Corp. Note

Outcome of Board Meeting

BSE India

Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 11, 2010, have appointed:1. Mr. Saurabh Goyal on the Board as an Executive Director for a period of Five Years w.e.f. August 11, 2010, subject to the approval to the shareholders in their General Meeting.2. Mr. Ajay Swaroop on the Board as an additional director (Independent director) of the Company who shall hold the...

Nectar Lifesciences Ltd.

11 Aug 2010

Corp. Note

Financial Results for Jun 30, 2010

BSE India

Nectar Lifesciences Ltd has informed BSE about the Financial Results for the Quarter ended June 30, 2010.

pdf

Nectar Lifesciences Ltd.

01 Jun 2010

Annual Report

Annual report for Nectar Lifesciences Ltd. for FY-2010

pdf

Nectar Lifesciences Ltd.

28 May 2010

Corp. Note

Financial Results for Mar 31, 2010

BSE India

Nectar Lifesciences Ltd has informed BSE about the Financial Results for the Year ended March 31, 2010.

pdf

Nectar Lifesciences Ltd.

05 May 2010

Corp. Note

Publish Audited Results

BSE India

Nectar Lifesciences Ltd has informed BSE that the Company has opted to adopt the Audited Financial Results for the financial year ended March 31, 2010 within a period of 60 days from the end of the last quarter of the relevant financial year.The Company will therefore, not publish the un-audited quarterly results for the quarter ending March 31, 2010.

Nectar Lifesciences Ltd.

25 Mar 2010

Corp. Note

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE

pdf

Nectar Lifesciences Ltd.

25 Mar 2010

Corp. Note

Disclosures under Reg. 7(3) of SEBI (SAST) Regulations, 1997

BSE India

Nectar Lifesciences Ltd has submitted the disclosure under Regulation 7(3) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE

pdf

Is Nectar Lifesciences Ltd. worth buying?

155 Votes:

Buy 77.42%

Sell 16.77%

Hold 5.81%